The Evolution of Combination Therapies in the Treatment of Melanoma

September 27, 2013 | Jeffrey Infante, MD

Join Dr. Jeffrey Infante as he discusses the advances in combination therapies for melanoma, as well as the future of these treatments. Topics include:

  • B-Raf
  • Vemurafenib
  • Trametinib
  • Combination B-Raf/MEK
  • Other Targeted Combination Strategies
  • RAF & Immunotherapy Combinations
  • Sequencing Strategies


Jeffrey Infante, MD
Director of Drug Development, Sarah Cannon Research Institute
Hematologist/Oncologist, Tennessee Oncology PLLC

Catherine Poole, Melanoma International Foundation

Presented by Jeffrey Infante, MD

Related Webinars

Decision Making for Melanoma: Stage III & Beyond

Presented by Jason J. Luke
January 07, 2016

Surgical Management of Melanoma: A 2015 Primer

Presented by Jeffrey Gershenwald, MD
May 09, 2015

Melanoma 101: A Brighter Outlook

Presented by David Fisher, MD PhD, MD PhD
December 01, 2014
See All Webinars